Arcinova provides full synthesis of drug substance and support services to a number of key US Biotech clients with a track record in delivering on projects and in the provision of drug substance manufacturing technology, which our clients are patenting.
We run a one stop development and kilo scale manufacturing facility, ensuring a service provision of manufacturing processes, which can be scaled from grams to multi-kg batch size with further kilolab/pilot plant capabilities up to 100’s Kg. We are strong in route selection, process development and impurity tracking / control through our onsite process chemistry, radiolabelled synthesis, analytical and drug development teams. We innovatively develop bespoke solutions for technically difficult challenges and give our customers a better deal in terms of speed, cost and quality.
MHRA SymposiumThe 2018 MHRA Symposium will be attended by John McRoberts, Head of QA.
MHRA SymposiumDates: 20th NovemberLocation: London, UK
AAPS: PharmSci360This years' PharmSci360 conference will be attended by Masha Kononov, Senior Director Emerging Biotech US.
AAPS: PharmSci360Dates: 4th - 7th NovemberLocation: Washington DC, US
Bio-Europe 2018Bio-Europe autumn conference will be attended by Nathalie Huther, Business Development Manager Europe.
Bio-Europe 2018Dates: 5th - 7th NovemberLocation: Copenhagen, Denmark